1. Home
  2. NSPR vs BGSF Comparison

NSPR vs BGSF Comparison

Compare NSPR & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • BGSF
  • Stock Information
  • Founded
  • NSPR 2005
  • BGSF 2007
  • Country
  • NSPR United States
  • BGSF United States
  • Employees
  • NSPR N/A
  • BGSF N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • BGSF Professional Services
  • Sector
  • NSPR Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • NSPR 74.8M
  • BGSF 63.6M
  • IPO Year
  • NSPR N/A
  • BGSF N/A
  • Fundamental
  • Price
  • NSPR $2.38
  • BGSF $5.64
  • Analyst Decision
  • NSPR Strong Buy
  • BGSF Strong Buy
  • Analyst Count
  • NSPR 2
  • BGSF 1
  • Target Price
  • NSPR $4.50
  • BGSF $9.00
  • AVG Volume (30 Days)
  • NSPR 112.3K
  • BGSF 30.3K
  • Earning Date
  • NSPR 08-05-2025
  • BGSF 08-06-2025
  • Dividend Yield
  • NSPR N/A
  • BGSF N/A
  • EPS Growth
  • NSPR N/A
  • BGSF N/A
  • EPS
  • NSPR N/A
  • BGSF N/A
  • Revenue
  • NSPR $7,066,000.00
  • BGSF $266,615,000.00
  • Revenue This Year
  • NSPR $4.85
  • BGSF N/A
  • Revenue Next Year
  • NSPR $113.47
  • BGSF N/A
  • P/E Ratio
  • NSPR N/A
  • BGSF N/A
  • Revenue Growth
  • NSPR 7.60
  • BGSF 28.60
  • 52 Week Low
  • NSPR $1.99
  • BGSF $2.91
  • 52 Week High
  • NSPR $3.80
  • BGSF $9.06
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.93
  • BGSF 43.58
  • Support Level
  • NSPR $2.35
  • BGSF $5.47
  • Resistance Level
  • NSPR $2.52
  • BGSF $5.77
  • Average True Range (ATR)
  • NSPR 0.14
  • BGSF 0.40
  • MACD
  • NSPR -0.02
  • BGSF -0.07
  • Stochastic Oscillator
  • NSPR 7.50
  • BGSF 12.07

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

Share on Social Networks: